The Acute Respiratory Distress Syndrome (ARDS) market was valued at USD 339.36 Billion in 2024 and is expected to reach USD 732.76 Billion by 2032, growing at a CAGR of 10.1% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.